Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,780 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
Yamaguchi K, Yamaguchi A, Kashiwagi C, Sawada Y, Taguchi K, Umetsu K, Oshima K, Uchida M, Suzuki M, Kono S, Takemura M, Masubuchi H, Kitahara S, Hara K, Maeno T, Motegi SI, Muro Y, Sakairi T, Hisada T, Kurabayashi M. Yamaguchi K, et al. Among authors: taguchi k. Respir Med. 2018 Jul;140:1-5. doi: 10.1016/j.rmed.2018.05.010. Epub 2018 May 22. Respir Med. 2018. PMID: 29957268 Free article.
Clinical features of patients with anti-melanoma differentiation-associated gene-5 antibody-positive dermatomyositis complicated by spontaneous pneumomediastinum.
Yamaguchi K, Yamaguchi A, Itai M, Kashiwagi C, Takehara K, Aoki S, Sawada Y, Taguchi K, Umetsu K, Oshima K, Uchida M, Takemura M, Hara K, Motegi SI, Muro Y, Nakasatomi M, Sakairi T, Hiromura K, Kurabayashi M, Maeno T. Yamaguchi K, et al. Among authors: taguchi k. Clin Rheumatol. 2019 Dec;38(12):3443-3450. doi: 10.1007/s10067-019-04729-5. Epub 2019 Aug 16. Clin Rheumatol. 2019. PMID: 31420814
Clinical features of dermatomyositis associated with anti-MDA5 antibodies by age.
Yamaguchi K, Yamaguchi A, Onuki Y, Itai M, Kashiwagi C, Takehara K, Aoki S, Kanaya A, Taguchi K, Umetsu K, Oshima K, Uchida M, Kimura H, Kasahara M, Takemura M, Hara K, Sekiguchi A, Motegi SI, Muro Y, Nakasatomi M, Motohashi R, Sakairi T, Nakagawa J, Hiromura K, Obokata M, Kurabayashi M, Maeno T. Yamaguchi K, et al. Among authors: taguchi k. Mod Rheumatol. 2021 Jan;31(1):177-185. doi: 10.1080/14397595.2020.1740400. Epub 2020 Mar 30. Mod Rheumatol. 2021. PMID: 32149542
Immune-related adverse events caused by treatment with pembrolizumab in a patient with lung cancer who infected influenza virus.
Takemura M, Motegi M, Kuroiwa Y, Itai M, Taguchi K, Umetsu K, Uchida M, Kounoc S, Sato M, Masubuchi H, Yamaguchi A, Yamaguchi K, Ikeda K, Nakagawa J, Maeno T. Takemura M, et al. Among authors: taguchi k. Respir Med Case Rep. 2021 Feb 2;32:101361. doi: 10.1016/j.rmcr.2021.101361. eCollection 2021. Respir Med Case Rep. 2021. PMID: 33643837 Free PMC article.
Interstitial lung disease with myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis in elderly patients.
Yamaguchi K, Yamaguchi A, Itai M, Onuki Y, Shin Y, Uno S, Hanazato C, Taguchi K, Umetsu K, Aikawa M, Kouno S, Takemura M, Hara K, Motegi S, Tsukida M, Ota F, Tsukada Y, Motegi M, Nakasatomi M, Sakairi T, Ikeuchi H, Kaneko Y, Hiromura K, Maeno T. Yamaguchi K, et al. Among authors: taguchi k. Rheumatol Int. 2021 Sep;41(9):1641-1650. doi: 10.1007/s00296-021-04891-7. Epub 2021 May 30. Rheumatol Int. 2021. PMID: 34056682
Predictive significance of circulating tumor DNA against patients with T790M-positive EGFR-mutant NSCLC receiving osimertinib.
Yamaguchi O, Kasahara N, Soda H, Imai H, Naruse I, Yamaguchi H, Itai M, Taguchi K, Uchida M, Sunaga N, Maeno T, Minato K, Tomono H, Ogawara D, Mukae H, Miura Y, Shiono A, Mouri A, Kagamu H, Kaira K. Yamaguchi O, et al. Among authors: taguchi k. Sci Rep. 2023 Nov 27;13(1):20848. doi: 10.1038/s41598-023-48210-5. Sci Rep. 2023. PMID: 38012343 Free PMC article.
Relationship between nephrotoxicity and area under the concentration-time curve of vancomycin in critically ill patients: a multicenter retrospective study.
Ishigo T, Matsumoto K, Yoshida H, Tanaka H, Ibe Y, Fujii S, Fukudo M, Fujihara H, Yamaguchi F, Ebihara F, Maruyama T, Hamada Y, Samura M, Nagumoi F, Komatsu T, Tomizawa A, Takuma A, Chiba H, Nishi Y, Enoki Y, Taguchi K, Suzuki A. Ishigo T, et al. Among authors: taguchi k. Microbiol Spectr. 2024 May 22:e0373923. doi: 10.1128/spectrum.03739-23. Online ahead of print. Microbiol Spectr. 2024. PMID: 38775483 Free article.
Bag1 protein loss sensitizes mouse embryonic fibroblasts to glutathione depletion.
Inose-Maruyama A, Irokawa H, Takeda K, Taguchi K, Morita M, Yamamoto M, Sasaki M, Kuge S. Inose-Maruyama A, et al. Among authors: taguchi k. Cell Stress Chaperones. 2024 May 17;29(3):497-509. doi: 10.1016/j.cstres.2024.05.003. Online ahead of print. Cell Stress Chaperones. 2024. PMID: 38763404 Free article.
The aged tumor microenvironment limits T cell control of cancer.
Chen ACY, Jaiswal S, Martinez D, Yerinde C, Ji K, Miranda V, Fung ME, Weiss SA, Zschummel M, Taguchi K, Garris CS, Mempel TR, Hacohen N, Sen DR. Chen ACY, et al. Among authors: taguchi k. Nat Immunol. 2024 May 14. doi: 10.1038/s41590-024-01828-7. Online ahead of print. Nat Immunol. 2024. PMID: 38745085
1,780 results